Nasal Drug Delivery Technologies Market By Dosage Form (Sprays, Drops & Liquids, Powders, Gels, Others), Container (Pressurized Containers, Non-pressurized Containers), System (Multi-dose Systems, Bi-dose Systems, Unit-dose Systems), Therapeutic Applications (Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination, Others), Industry Trends, Estimation & Forecast, 2017 - 2025

March 2019

 ERC 9616


Nasal drug delivery technology is the administration of drug through the nasal route. The nasal cavity is an easily accessible route which is generally used for drug delivery. Drugs administered through the nasal route are available in different forms, such as liquid drops, liquid spray, aerosol, suspension spray and gel. The drugs are given in multi dose as well as single dose. Intranasal medicine administration offers a needleless solution to drug delivery. Nasal airway technology is to protect the lungs from harmful contacts, despite acting as a delivery route for drugs.

Market Determinants

Developing acceptance of self-administration practices and growth of over the counter nasal medications are major factors driving the growth of nasal drug delivery market. Moreover, rapid research, development and adoption of new drug delivery technologies and devices, fast onset of action, reformulation of oral drugs and injections into the formulations to be administered by nasal route are also driving the growth of nasal drug delivery market. However, drug formulation failure and technical barrier are restrain the market growth. Additionally, complications created due improper usage of nasal splashes also hamper the market growth. On the other hand, growth among over the counter nasal drugs and increasing focus on alternative routes of drug delivery such as nasal drug delivery, will offer impressive growth opportunities to players operating in this market.

Segment Analysis

The nasal drug delivery technologies market is segmented by dosage form, container, system, therapeutic application, end user and geography. On the basis of dosage form, the nasal drug delivery technologies market is segmented into sprays, drops & liquids, powders, gels, and others. On the basis of container, the nasal drug delivery technologies market is segmented into pressurized containers and non-pressurized containers. By system, nasal drug delivery technologies market is segmented into multi-dose systems, bi-dose systems, and unit-dose systems. On the basis of therapeutic application, nasal drug delivery technologies market is segmented into allergic & non-allergic rhinitis, nose congestion, vaccination, and others. On the basis of end user, nasal drug delivery technologies market is segmented into home care settings and hospitals. By geography, the clinical trial management market is categorized as North America, Europe, Asia Pacific and Rest of World.
New product innovation and acquisition are the major strategies adopted by the key market players of nasal drug delivery technology market. In 2016, Johnson & Johnson completed acquisition of Abbott medical optics in order to expand its business platform.

The key players operating in this market include Merck & Co., Inc., Novartis AG, Johnson & Johnson, Pfizer Inc., AstraZeneca, AptarGroup, Inc., GlaxoSmithKline plc., Aegis Therapeutics LLC. and Becton, Dickinson & Company.

Nasal Drug Delivery Technologies Market Key Segments

o By Dosage Form
• Sprays
• Drops & Liquids
• Powders
• Gels
• Others

o By Container
• Pressurized Containers
• Non-pressurized Containers
o By System
• Multi-dose Systems
• Bi-dose Systems
• Unit-dose Systems
o By Therapeutic Applications
• Allergic & Non-allergic Rhinitis
• Nose Congestion
• Vaccination
• Others

o By End User
• Home Care Settings
• Hospitals
o By Geography
o North America

  • U.S.
  • Canada
  • Mexico

o Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

o Asia-Pacific

  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific

o Rest of World

  •  Brazil
  •  Saudi Arabia
  •  South Africa
  •  Rest of World

Key Market Player

o Novartis AG
o Pfizer Inc.
o AstraZeneca
o AptarGroup, Inc.
o GlaxoSmithKline plc.
o Aegis Therapeutics LLC.
o Becton, Dickinson & Company.
o Johnson & Johnson
o Merck & Co., Inc.

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Nasal Drug Delivery Technologies Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Nasal Drug Delivery Technologies Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!